Edition:
United States

Viveve Medical Inc (VIVE.OQ)

VIVE.OQ on NASDAQ Stock Exchange Capital Market

4.90USD
11 Dec 2017
Change (% chg)

-- (--)
Prev Close
$4.90
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
41,776
52-wk High
$11.16
52-wk Low
$3.75

Chart for

About

Viveve Medical, Inc. designs, develops, manufactures and markets a medical device, Geneveve, for the non-invasive treatment of vaginal laxity, for improved sexual function, and for vaginal rejuvenation. The Company's, Geneveve, is a non-invasive solution for vaginal laxity, which includes three components: the Viveve System (a... (more)

Overall

Beta: -0.68
Market Cap(Mil.): $95.19
Shares Outstanding(Mil.): 19.43
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 28.30 15.71
EPS (TTM): -- -- --
ROI: -- 10.04 31.93
ROE: -- 15.26 16.16

BRIEF-Viveve Medical Inc files for mixed shelf of up to $50 million

* Viveve Medical Inc files for mixed shelf of up to $50 million Source text: (http://bit.ly/2zIf6EQ) Further company coverage:

Nov 08 2017

BRIEF-Viveve reports Q3 loss per share $0.50

* Q3 earnings per share view $-0.42 -- Thomson Reuters I/B/E/S

Nov 08 2017

BRIEF-Viveve releases preliminary Q3 2017 financial results

* Viveve releases preliminary third quarter 2017 financial results

Oct 18 2017

BRIEF-Viveve gets regulatory nod to market Viveve System in Mexico

* Viveve announces regulatory approval for Viveve System in Mexico

Oct 17 2017

BRIEF-Viveve announces regulatory approval for Viveve System in Taiwan

* Viveve announces regulatory approval for Viveve System in Taiwan

Oct 10 2017

BRIEF-Viveve announces additional regulatory approvals in Middle East

* Viveve announces additional regulatory approvals in Middle East

Sep 12 2017

BRIEF-Viveve Medical entered into a membership unit subscription agreement with ICM

* Viveve Medical Inc - in connection with distribution agreement, company also entered into a membership unit subscription agreement with ICM

Aug 10 2017

BRIEF-Viveve Medical reports Q2 loss per share $0.54

* Viveve announces second quarter 2017 financial results and strategic partnership with Incontrol Medical, Llc

Aug 10 2017

Earnings vs. Estimates